Enhanced S-Cone Syndrome Masquerading as TORCH in an Infant and a Toddler

References

• de Campos VS, Calaza KC, Adesse D. Implications of TORCH diseases in retinal development-special focus on congenital toxoplasmosis. Front Cell Infect Microbiol. October 26, 2020;10:585727. doi:10.3389/fcimb.2020.585727.
   PubMed Web of Science ®Google Scholar
• Baraitser M, Brett EM, Piesowicz AT. Microcephaly and intracranial calcification in two brothers. J Med Genet. June 1983;20(3):210–212. doi:10.1136/jmg.20.3.210.
   PubMed Web of Science ®Google Scholar
• Burn J, Wickramasinghe HT, Harding B, Baraitser M. A syndrome with intracranial calcification and microcephaly in two sibs, resembling intrauterine infection. Clin Genet. August 1986;30(2):112–116. doi:10.1111/j.1399-0004.1986.tb00578.x. PMID: 3757300.
   PubMed Web of Science ®Google Scholar
• Reardon W, Hockey A, Silberstein P, et al. Autosomal recessive congenital intrauterine infection-like syndrome of microcephaly, intracranial calcification, and CNS disease. Am J Med Genet. August 1, 1994;52(1):58–65. doi:10.1002/ajmg.1320520112.
   PubMed Web of Science ®Google Scholar
• Vivarelli R, Grosso S, Cioni M, et al. Pseudo-TORCH syndrome or Baraitser-Reardon syndrome: diagnostic criteria. Brain Dev. March 2001;23(1):18–23. doi:10.1016/s0387-7604(00)00188-1. PMID: 11226724.
   PubMed Web of Science ®Google Scholar
• Bandah D, Merin S, Ashhab M, Banin E, Sharon D. The spectrum of retinal diseases caused by NR2E3 mutations in Israeli and Palestinian patients. Arch Ophthalmol. March 2009;127(3):297–302. doi:10.1001/archophthalmol.2008.615.
   PubMedGoogle Scholar
• Hull S, Arno G, Sergouniotis PI, et al. Clinical and molecular characterization of enhanced S-cone syndrome in children. JAMA Ophthalmol. November 2014;132(11):1341–1349. doi:10.1001/jamaophthalmol.2014.2343.
   PubMed Web of Science ®Google Scholar
• Yzer S, Barbazetto I, Allikmets R, et al. Expanded clinical spectrum of enhanced S-cone syndrome. JAMA Ophthalmol. October 2013;131(10):1324–1330. doi:10.1001/jamaophthalmol.2013.4349.
   PubMed Web of Science ®Google Scholar
• Nowilaty SR, Alsalamah AK, Magliyah MS, et al. Incidence and natural history of retinochoroidal neovascularization in enhanced S-cone syndrome. Am J Ophthalmol. 2021;222:174–184. doi:10.1016/j.ajo.2020.09.010.
   PubMed Web of Science ®Google Scholar
• Bazvand F, Khojasteh H, Zarei M. Novel findings in enhanced S-cone syndrome: a case with macular retinal neovascularization and severe retinal vasculitis. Doc Ophthalmol. Dec 2019;139(3):221–226. doi:10.1007/s10633-019-09706-6.
   PubMed Web of Science ®Google Scholar
• Atmaca LS, Simsek T, Batioglu F. Clinical features and prognosis in ocular toxoplasmosis. Jpn J Ophthalmol. 2004;48:386–391. doi:10.1007/s10384-003-0069-0.
   PubMed Web of Science ®Google Scholar
• Skorska I, Soubrane G, Coscas G. Toxoplasmic choroiditis and subretinal neovessels. J Fr Ophtalmol. 1984;7:211–218.
   PubMedGoogle Scholar
• Hegde S, Relhan N, Pathengay A, et al. Coexisting choroidal neovascularization and active retinochoroiditis-an uncommon presentation of ocular toxoplasmosis. J Ophthalmic Inflamm Infect. Jul 12, 2015;5:22. doi:10.1186/s12348-015-0051-2.
   PubMedGoogle Scholar
• Monshizadeh R, Ashrafzadeh, Rumelt S. Choroidal neovascular membrane: a late complication of inactive toxocara chorioretinitis. Retina. 2000;20(2):219–220. doi:10.1097/00006982-200002000-00022.
   PubMed Web of Science ®Google Scholar
• Yoon DY, Woo SJ. Intravitreal administration of ranibizumab and bevacizumab for choroidal neovascularization secondary to ocular toxocariasis: a case report. Ocul Immunol Inflamm. 2018;26(4):639–641. doi:10.1080/09273948.2016.1239744.
   PubMed Web of Science ®Google Scholar
• Lyall DAM, Hutchison BM, Gaskell A, Varikkara M. Intravitreal ranibizumab in the treatment of choroidal neovascularisation secondary to ocular toxocariasis in a 13-year-old boy. Eye. 2010;24(11):1730–1731. doi:10.1038/eye.2010.131.
   PubMed Web of Science ®Google Scholar
• Higashide T, Akao N, Shirao E, Shirao Y. Optical coherence tomographic and angiographic findings of a case with subretinal toxocara granuloma. Am J Ophthalmol. July 2003;136(1):188–190. doi:10.1016/s0002-9394(03)00079-5.
   PubMed Web of Science ®Google Scholar
• Kozak I, Mansour A, Diaz RI, et al., King Khaled Eye Specialist Hospital International Collaborative Retina Study Group. Outcomes of treatment of pediatric choroidal neovascularization with intravitreal antiangiogenic agents: the results of the KKESH international collaborative retina study group. Retina. 2014;34(10):2044–2052. doi:10.1097/IAE.0000000000000200.
   PubMed Web of Science ®Google Scholar
• Rishi P, Gupta A, Rishi E, Shah BJ. Choroidal neovascularization in 36 eyes of children and adolescents. Eye (Lond). 2013;27:1158–1168. doi:10.1038/eye.2013.155.
   PubMed Web of Science ®Google Scholar
• Nakamura M, Hotta Y, Piao CH, Kondo M, Terasaki H, Miyake Y. Enhanced S-cone syndrome with subfoveal neovascularization. Am J Ophthalmol. 2002;133(4):575–577. doi:10.1016/s0002-9394(01)01428-3.
   PubMed Web of Science ®Google Scholar
• Bertoli F, Pignatto S, Rizzetto F, Lanzetta P. A 5-year-old case of choroidal neovascularization in enhanced S-cone syndrome treated with ranibizumab. Case Rep Ophthalmol. 2018;9(3):510–515. doi:10.1159/000495743. Published 2018 Dec 21.
   PubMed Web of Science ®Google Scholar
• Badami K, Sultana A, Sinha B, Ijeri R, Jayadev C, Tsang SH. Diagnostic and therapeutic challenges. Retina. 2015;35(9):1911–1918. doi:10.1097/iae.0000000000000407.
   PubMed Web of Science ®Google Scholar
• Marmor MF, Jacobson SG, Foerster MH, Kellner U, Weleber RG. Diagnostic clinical findings of a new syndrome with night blindness, maculopathy, and enhanced S cone sensitivity. Am J Ophthalmol. 1990;110(2):124–134. doi:10.1016/s0002-9394(14)76980-6.
   PubMed Web of Science ®Google Scholar
• Lam BL, Goldberg JL, Hartley KL, Stone EM, Liu M. Atypical mild enhanced S-cone syndrome with novel compound heterozygosity of the NR2E3 gene. Am J Ophthalmol. July 2007;144(1):157–159. doi:10.1016/j.ajo.2007.03.012.
   PubMed Web of Science ®Google Scholar
• Sambricio J, Tejada-Palacios P, Barceló-Mendiguchía A. Choroidal neovascularization, outer retinal tubulation and fundus autofluorescence findings in a patient with enhanced S-cone syndrome. Clin Exp Ophthalmol. January-February 2016;44(1):69–71. doi:10.1111/ceo.12578.
   PubMed Web of Science ®Google Scholar
• Broadhead GK, Grigg JR, McCluskey P, Korsakova M, Chang AA. Bevacizumab for choroidal neovascularisation in enhanced S-cone syndrome. Doc Ophthalmol. October 2016;133(2):139–143. doi:10.1007/s10633-016-9555-9.
   PubMed Web of Science ®Google Scholar
• Maldonado RS, Zein WM, Cukras C. Multimodal evidence of type 3 neovascularization in enhanced S-cone syndrome. Retin Cases Brief Rep. July 24, 2019. doi:10.1097/ICB.0000000000000892.
   Google Scholar
• Zerbib J, Blanco Garavito R, Gerber S, et al. Retinochoroidal anastomosis associated with enhanced S-cone syndrome. Retin Cases Brief Rep. Fall 2019;13(4):295–299. doi:10.1097/ICB.0000000000000594.
   PubMedGoogle Scholar